RBC Europe’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-1,500
| Closed | -$2.99K | – | 1115 |
|
2020
Q2 | $2.99K | Hold |
1,500
| – | – | ﹤0.01% | 918 |
|
2020
Q1 | $2.93K | Hold |
1,500
| – | – | ﹤0.01% | 880 |
|
2019
Q4 | $6.23K | Hold |
1,500
| – | – | ﹤0.01% | 882 |
|
2019
Q3 | $4.52K | Hold |
1,500
| – | – | ﹤0.01% | 904 |
|
2019
Q2 | $9.44K | Hold |
1,500
| – | – | ﹤0.01% | 812 |
|
2019
Q1 | $8.34K | Hold |
1,500
| – | – | ﹤0.01% | 854 |
|
2018
Q4 | $9.96K | Hold |
1,500
| – | – | ﹤0.01% | 786 |
|
2018
Q3 | $16K | Hold |
1,500
| – | – | ﹤0.01% | 737 |
|
2018
Q2 | $18K | Hold |
1,500
| – | – | ﹤0.01% | 698 |
|
2018
Q1 | $12.9K | Hold |
1,500
| – | – | ﹤0.01% | 775 |
|
2017
Q4 | $14.8K | Hold |
1,500
| – | – | ﹤0.01% | 753 |
|
2017
Q3 | $18.4K | Buy |
+1,500
| New | +$18.4K | ﹤0.01% | 696 |
|